Daniel Korvin serves as the Chief Technology Officer and Research Lead at Lux Bio since July 2020. Prior to this role, Daniel was the Bioprocess Development Team Lead and Bioprocess Scientist at Hyasynth Bio from August 2018 to May 2020. Daniel holds a Master of Applied Science in Chemical and Biological Engineering from The University of British Columbia, obtained in 2018, and a Bachelor of Science in Microbiology and Immunology from the same institution, completed in 2014.
This person is not in any teams
This person is not in any offices